Frontage Clinical Services Trials

Frontage Clinical Services	Welcome, Profile Billing Logout

54 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Dao, Kim-Hien

NHLBI-MDS, NCT02775383: The National Myelodysplastic Syndromes (MDS) Study

Active, not recruiting

N/A

3500

US, RoW

Therapeutic

National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI)

Myelodysplastic Syndromes (MDS)

03/25

06/25

Manager, Project

MAGNAM, NCT05287191: Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care

Recruiting

200

Canada

Magnesium sulfate and then Digoxin, Amiodarone

Sunnybrook Health Sciences Centre, Sunnybrook Research Institute

Atrial Fibrillation New Onset

10/25

04/26

LANTERN, NCT06702878: Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

Recruiting

4514

nasal antimicrobial photodisinfection therapy

Ondine Biomedical Inc.

Surgical Site Infections, Surgical Wound Infection, Infections, Anti-Infective Agents

07/25

08/25

PEMDA-HN, NCT05814666: Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC

Recruiting

Europe, US, RoW

Danvatirsen, ISIS 481464, AZD9150, Pembrolizumab, Keytruda

Flamingo Therapeutics NV

HNSCC

05/25

05/26

NCT05714657: Shortened Course Adjuvant Radiotherapy Following TORS

Recruiting

104

Shortened Course Adjuvant Radiotherapy Following TORS

Abramson Cancer Center at Penn Medicine

HPV-Associated Oropharyngeal Squamous Cell Carcinoma

12/25

04/26

NCT06591819: Hypofractionated WPPT With HDR Boost

Recruiting

Hypofractionated Whole Pelvis Proton Therapy with Brachytherapy Boost

Abramson Cancer Center at Penn Medicine

Prostate Cancer

01/26

12/31

TILS-022, NCT06890923: Nasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis

Recruiting

Foralumab TZLS-401 100 µg

Tiziana Life Sciences LTD

Non-Active Secondary Progressive Multiple Sclerosis

04/26

08/26

GynWPProton, NCT05758688: PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Recruiting

Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT)

Abramson Cancer Center at Penn Medicine

Cervical Cancer, Uterine Cancer, Endometrial Cancer

05/26

11/26

TRAK-ER, NCT04985266 / 2020-004022-36: A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer

Recruiting

1100

Europe

Palbociclib 125Mg Tab, Fulvestrant injection, Tamoxifen, Letrozole, Exemestane, Anastrozole

Royal Marsden NHS Foundation Trust, Pfizer, AstraZeneca, Institute of Cancer Research, United Kingdom, UNICANCER, Gustave Roussy, Cancer Campus, Grand Paris, Invitae Corporation

ER+ Breast Cancer, HER2-negative Breast Cancer

09/27

09/30

NCT05029401: A Study of Oral Ibogaine in Opioid Withdrawal

Completed

1/2

116

Europe

DMX-1002, Ibogaine Hydrochloride, Placebo, Microcrystalline cellulose

atai Therapeutics, Inc., MAC Clinical Research, ERT: Clinical Trial Technology Solutions, Hammersmith Medicines Research

Opiate Withdrawal Syndrome

01/24

PROSPER, NCT06244771: A Study Evaluating FMC-376 in Participants with KRAS G12C Mutated Solid Tumors

Recruiting

1/2

403

FMC-376

Frontier Medicines Corporation

Advanced Solid Tumors with KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor, Metastatic Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer, KRAS G12C, Pancreatic Cancer

10/27

04/28

APT-CUBE, NCT05473156: A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies

Recruiting

1/2

168

RoW

AP203

AP Biosciences Inc.

Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC), Esophageal Squamous Cell Carcinoma (ESCC)

12/26

12/27

NCT05450549: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants

Completed

Europe

DNL919, Placebo

Denali Therapeutics Inc., Takeda

Healthy Participant

06/23

NCT03832985: Pediatric Reporting of Adult-Onset Genomic Results

Completed

427

Receive an adult-onset result, Receive a pediatric-onset result, Control - No Result

Geisinger Clinic, National Human Genome Research Institute (NHGRI)

Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome, Familial Hypercholesterolemia

10/24

MV371 LAI FiH, NCT06558643: Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants

Recruiting

Europe

MMV371 LAI, Placebo for MMV371

Medicines for Malaria Venture, Quotient Sciences, The Doctors Laboratory Ltd

Malaria,Falciparum

08/25

NCT06639724: Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

Recruiting

Fostamatinib in combination with chemotherapy (gemcitabine and nab-paclitaxel)

University of California, San Diego, Rigel Pharmaceuticals

Pancreatic Ductal Adenocarcinoma (PDAC)

06/27

12/28

NCT06586255: Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

Recruiting

Concurrent Immunotherapy and Radiation Therapy

Abramson Cancer Center at Penn Medicine

Urothelial Carcinoma Bladder, Bladder Cancer

04/27

ENHANCE, NCT05866471: The Study: taVNS and Psilocybin

Recruiting

108

Psilocybin, Psilocybine, Psilocibin, Filament Health Psilocybin, PEX010, Transcutaneous auricular Vagus Nerve Stimulation (taVNS), Psychosocial Support Alone, Sham taVNS

University of Wisconsin, Madison, Tiny Blue Dot Foundation

Healthy, Psychedelic Experiences, Vagus Nerve Stimulation

11/27

01/28

NCT06129084: A Study to Compare the Results of FGFR Testing by Either CtDNA Blood Testing or Standard Tumor Tissue Testing

Recruiting

N/A

260

Canada

FGFR Testing

Bernie Eigl, Vancouver Prostate Centre, Lady Davis Institute, Bladder Cancer Canada

Metastatic Bladder Cancer, Metastatic Urothelial Carcinoma

03/25

05/25

Focused-PPC, NCT05280951: An Integrated Postpartum Care, Education, and Support Model for Women in Ghana

Recruiting

N/A

192

RoW

Focused-PPC Care, Usual Care

University of Notre Dame, Savana Signatures, Indiana University School of Medicine

Postpartum Care

01/23

06/23

DIAGNOSE CRDS, NCT06188689: Evaluation of A Clinical Diagnostic Test for CRDS

Recruiting

N/A

400

Europe, Canada, US, RoW

Pacing

Population Health Research Institute, Canadian Institutes of Health Research (CIHR)

Calcium Release Deficiency Syndrome (CRDS)

12/25

03/26

HBS Ancillary, NCT04794543: Effects of Using E-Cigarettes on Lungs in People With HIV

Completed

N/A

Pennington Biomedical Research Center, National Institute of General Medical Sciences (NIGMS)

Hiv, Lung Injury

08/23

12/23

CAE-E, NCT04622150: Effectiveness RCT of Customized Adherence Enhancement

Recruiting

N/A

190

Customized Adherence Enhancement (CAE), Enhanced Treatment as Usual (eTAU)

Case Western Reserve University, National Institute of Mental Health (NIMH)

Bipolar Disorder

11/25

05/26

TECHWISE, NCT06664944: Technology Exposure and Child Health: Wellness Impact and Social Effects: an Observational Product Registry Study

Recruiting

N/A

1000

Aura

Mood, Depression Disorders, Anxiety Disorders, Sleep, Eating Disorders, Physical Activity, Loneliness, Stress

12/25

CRDS Registry, NCT06508164: International

Recruiting

N/A

500

Europe, Canada, RoW

Population Health Research Institute, Canadian Institutes of Health Research (CIHR)

Calcium Release Deficiency Syndrome

12/50

NCT06833268: Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan

Recruiting

N/A

220

No drug

Daiichi Sankyo

HER2-positive Breast Cancer

06/25

NCT06812117: A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)

Recruiting

N/A

720

RoW

No Drug

Daiichi Sankyo

Diabetic Peripheral Neuropathic Pain

02/26

04/26

PEERS, NCT06696066: Pilot: Peer Recovery Support Program to Support Engagement in Medication for Opioid Use Disorder

Recruiting

N/A

PRS Program

Geisinger Clinic, National Institute on Drug Abuse (NIDA), UConn Health

Opioid Use Disorder

06/25

08/25

RERUN, NCT06809764: Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC

Recruiting

N/A

150

RoW

No drug

Daiichi Sankyo

Non-small Cell Lung Cancer

02/27

RECOVER, NCT06846996: Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China

Recruiting

N/A

260

RoW

Trastuzumab deruxtecan (T-DXd)

Daiichi Sankyo

HER2-positive Gastric Cancer, HER2-positive Gastroesophageal Junction

07/27

NCT06659900: Community Vital Signs (CVS): an Integrated Community-Based Approach to Identify Undiagnosed Hypertension in Nigeria

Not yet recruiting

N/A

24000

RoW

CORE Plus (+), CORE

Oregon Health and Science University, University of Nigeria Nsukka

Hypertension

06/27

IMPACT, NCT04330833: Informational Meetings for Planning and Coordinating Treatment

Active, not recruiting

N/A

110

Novel Communication Intervention, Enhanced Usual Care Parent Education

Indiana University, National Cancer Institute (NCI)

End of Life, Communication, Cancer Metastatic

07/25

N&HS, NCT06950775: The Neighborhood & Health Study

Not yet recruiting

N/A

600

Residence in Agrihood Neighborhood

Texas A&M University

Healthy Eating, Cardiometabolic Health Indicators

03/26

ASPIRE-II, NCT06668350: Attitudes and Perceptions Attitudes and Smoking Perceptions in the Real Environment -II

Not yet recruiting

N/A

190

Smoking outcomes

University of Oklahoma

Cigarillo Flavor

02/29

06/29

NCT06776406: Head Stabilization in Whole Brain RT

Not yet recruiting

N/A

Freedom Pursuit Robotic Platform

Abramson Cancer Center at Penn Medicine

Brain Cancer

08/27

Safe-De, NCT05058183: Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer

Recruiting

N/A

400

Europe

ctDNA

Royal Marsden NHS Foundation Trust, Massachusetts General Hospital, Natera, Inc.

Breast Cancer

12/25

12/28

NCT05568264: Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

Recruiting

N/A

192

Physical Therapy intervention

Shirley Ryan AbilityLab, Ann & Robert H Lurie Children's Hospital of Chicago, Northwestern University, Northwestern Medicine, University of Illinois at Chicago

Motor Delay, Premature Birth, Intraventricular Hemorrhage, Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia

05/26

12/26

NCT01577251: The Radiation Oncology Registry and Biosample Repository

Recruiting

N/A

8000

Abramson Cancer Center at Penn Medicine

Neoplasia

12/30

Diamond, Lisa

NCT02726360: Physician Use of Non-English Language Skills in Cancer Care

Completed

N/A

survey, ILR Scale, Audio record

Memorial Sloan Kettering Cancer Center, Edward-Elmhurst Health System, Johns Hopkins University, Lincoln Medical and Mental Health Center, Queens Cancer Center of Queens Hospital

Breast Cancer, Colon Cancer, Lung Cancer

08/23

Lee, Frank

OASIS, NCT06527937: Pharmacokinetics Study of DESF in Adults with Oral Allergy Syndrome

Completed

DESF, Epinephrine Injection

Aquestive Therapeutics

Allergic Reaction

10/24

NCT05499260: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants

Recruiting

CB03-154, Placebo

Shanghai Zhimeng Biopharma, Inc.

Healthy Volunteers

03/23

NCT05523570: A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension

Completed

HNC364, HNC364 injectable suspension

Guangzhou Henovcom Bioscience Co. Ltd.

Parkinson's Disease

04/24

NCT05750017: A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine

Recruiting

Low Dose Recombinant Herpes Zoster Vaccine (LZ901), High Dose Recombinant Herpes Zoster Vaccine (LZ901), Placebo, Saline solution

Beijing Luzhu Biotechnology Co., Ltd.

Herpes Zoster, Vaccine-Preventable Diseases

02/24

03/24

NCT06911242: A Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions

Recruiting

ARN-75039

Arisan Therapeutics, Inc.

Lassa Virus Infection

04/25

NCT05504200: Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training

Completed

N/A

Europe

Bladder and Pelvic Floor Muscle Training

RNOH RIC, International Spinal Research Trust

Spinal Cord Injuries

09/23

Prezioso, Alexander N

NCT05611957: A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Completed

LY3437943

Eli Lilly and Company

Healthy, Renal Insufficiency

09/23

NCT05936138: A Study of LY3502970 in Participants With Normal and Impaired Renal Function

Completed

LY3502970

Eli Lilly and Company

Renal Insufficiency, Healthy

04/24

DA-1726-1001, NCT06252220: First in Human Study in Subjects With Obesity, But Otherwise Healthy

Recruiting

DA-1726, Placebo to DA-1726

NeuroBo Pharmaceuticals Inc.

Obesity

03/25

06/25

NCT06498284: Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus

Completed

HM-002-1005, 1005

Hua Medicine Limited

Diabetes Mellitus, Type II

09/24

NCT05882032: A Study of LY3502970 in Participants With Impaired and Normal Liver Function

Completed

LY3502970

Eli Lilly and Company

Healthy, Hepatic Insufficiency

11/24

PMN310-101, NCT06105528: A Phase 1a Study of PMN310 In Healthy Volunteers

Completed

PMN310, Placebo

ProMis Neurosciences, Inc

Healthy Participants

07/24

NCT06606106: A Study of LY3537031 in Overweight, Obese, and Healthy Participants

Recruiting

230

LY3537031, Placebo

Eli Lilly and Company

Healthy, Obesity

07/26

NCT06824051: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight

Active, not recruiting

120

Orforglipron, LY3502970, Placebo

Eli Lilly and Company

Obesity, Overweight

12/25

NCT06916143: Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach Acid

Recruiting

LY4100511, Rabeprazole

Eli Lilly and Company

Healthy Participants

06/25

Liu, Jiabei Jay

No trials found

Christodoro, Dina

No trials found

Kim, Alicia

No trials found

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Dao, Kim-Hien

NHLBI-MDS, NCT02775383: The National Myelodysplastic Syndromes (MDS) Study

Active, not recruiting

N/A

3500

US, RoW

Therapeutic

National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI)

Myelodysplastic Syndromes (MDS)

03/25

06/25

Manager, Project

MAGNAM, NCT05287191: Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care

Recruiting

200

Canada

Magnesium sulfate and then Digoxin, Amiodarone

Sunnybrook Health Sciences Centre, Sunnybrook Research Institute

Atrial Fibrillation New Onset

10/25

04/26

LANTERN, NCT06702878: Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

Recruiting

4514

nasal antimicrobial photodisinfection therapy

Ondine Biomedical Inc.

Surgical Site Infections, Surgical Wound Infection, Infections, Anti-Infective Agents

07/25

08/25

PEMDA-HN, NCT05814666: Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC

Recruiting

Europe, US, RoW

Danvatirsen, ISIS 481464, AZD9150, Pembrolizumab, Keytruda

Flamingo Therapeutics NV

HNSCC

05/25

05/26

NCT05714657: Shortened Course Adjuvant Radiotherapy Following TORS

Recruiting

104

Shortened Course Adjuvant Radiotherapy Following TORS

Abramson Cancer Center at Penn Medicine

HPV-Associated Oropharyngeal Squamous Cell Carcinoma

12/25

04/26

NCT06591819: Hypofractionated WPPT With HDR Boost

Recruiting

Hypofractionated Whole Pelvis Proton Therapy with Brachytherapy Boost

Abramson Cancer Center at Penn Medicine

Prostate Cancer

01/26

12/31

TILS-022, NCT06890923: Nasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis

Recruiting

Foralumab TZLS-401 100 µg

Tiziana Life Sciences LTD

Non-Active Secondary Progressive Multiple Sclerosis

04/26

08/26

GynWPProton, NCT05758688: PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Recruiting

Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT)

Abramson Cancer Center at Penn Medicine

Cervical Cancer, Uterine Cancer, Endometrial Cancer

05/26

11/26

Recruiting

1100

Europe

Palbociclib 125Mg Tab, Fulvestrant injection, Tamoxifen, Letrozole, Exemestane, Anastrozole

Royal Marsden NHS Foundation Trust, Pfizer, AstraZeneca, Institute of Cancer Research, United Kingdom, UNICANCER, Gustave Roussy, Cancer Campus, Grand Paris, Invitae Corporation

ER+ Breast Cancer, HER2-negative Breast Cancer

09/27

09/30

NCT05029401: A Study of Oral Ibogaine in Opioid Withdrawal

Completed

1/2

116

Europe

DMX-1002, Ibogaine Hydrochloride, Placebo, Microcrystalline cellulose

atai Therapeutics, Inc., MAC Clinical Research, ERT: Clinical Trial Technology Solutions, Hammersmith Medicines Research

Opiate Withdrawal Syndrome

01/24

PROSPER, NCT06244771: A Study Evaluating FMC-376 in Participants with KRAS G12C Mutated Solid Tumors

Recruiting

1/2

403

FMC-376

Frontier Medicines Corporation

Advanced Solid Tumors with KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor, Metastatic Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer, KRAS G12C, Pancreatic Cancer

10/27

04/28

Recruiting

1/2

168

RoW

AP203

AP Biosciences Inc.

Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC), Esophageal Squamous Cell Carcinoma (ESCC)

12/26

12/27

NCT05450549: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants

Completed

Europe

DNL919, Placebo

Denali Therapeutics Inc., Takeda

Healthy Participant

06/23

NCT03832985: Pediatric Reporting of Adult-Onset Genomic Results

Completed

427

Receive an adult-onset result, Receive a pediatric-onset result, Control - No Result

Geisinger Clinic, National Human Genome Research Institute (NHGRI)

Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome, Familial Hypercholesterolemia

10/24

MV371 LAI FiH, NCT06558643: Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants

Recruiting

Europe

MMV371 LAI, Placebo for MMV371

Medicines for Malaria Venture, Quotient Sciences, The Doctors Laboratory Ltd

Malaria,Falciparum

08/25

NCT06639724: Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

Recruiting

Fostamatinib in combination with chemotherapy (gemcitabine and nab-paclitaxel)

University of California, San Diego, Rigel Pharmaceuticals

Pancreatic Ductal Adenocarcinoma (PDAC)

06/27

12/28

NCT06586255: Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

Recruiting

Concurrent Immunotherapy and Radiation Therapy

Abramson Cancer Center at Penn Medicine

Urothelial Carcinoma Bladder, Bladder Cancer

04/27

ENHANCE, NCT05866471: The Study: taVNS and Psilocybin

Recruiting

108

Psilocybin, Psilocybine, Psilocibin, Filament Health Psilocybin, PEX010, Transcutaneous auricular Vagus Nerve Stimulation (taVNS), Psychosocial Support Alone, Sham taVNS

University of Wisconsin, Madison, Tiny Blue Dot Foundation

Healthy, Psychedelic Experiences, Vagus Nerve Stimulation

11/27

01/28

NCT06129084: A Study to Compare the Results of FGFR Testing by Either CtDNA Blood Testing or Standard Tumor Tissue Testing

Recruiting

N/A

260

Canada

FGFR Testing

Bernie Eigl, Vancouver Prostate Centre, Lady Davis Institute, Bladder Cancer Canada

Metastatic Bladder Cancer, Metastatic Urothelial Carcinoma

03/25

05/25

Focused-PPC, NCT05280951: An Integrated Postpartum Care, Education, and Support Model for Women in Ghana

Recruiting

N/A

192

RoW

Focused-PPC Care, Usual Care

University of Notre Dame, Savana Signatures, Indiana University School of Medicine

Postpartum Care

01/23

06/23

DIAGNOSE CRDS, NCT06188689: Evaluation of A Clinical Diagnostic Test for CRDS

Recruiting

N/A

400

Europe, Canada, US, RoW

Pacing

Population Health Research Institute, Canadian Institutes of Health Research (CIHR)

Calcium Release Deficiency Syndrome (CRDS)

12/25

03/26

HBS Ancillary, NCT04794543: Effects of Using E-Cigarettes on Lungs in People With HIV

Completed

N/A

Pennington Biomedical Research Center, National Institute of General Medical Sciences (NIGMS)

Hiv, Lung Injury

08/23

12/23

CAE-E, NCT04622150: Effectiveness RCT of Customized Adherence Enhancement

Recruiting

N/A

190

Customized Adherence Enhancement (CAE), Enhanced Treatment as Usual (eTAU)

Case Western Reserve University, National Institute of Mental Health (NIMH)

Bipolar Disorder

11/25

05/26

TECHWISE, NCT06664944: Technology Exposure and Child Health: Wellness Impact and Social Effects: an Observational Product Registry Study

Recruiting

N/A

1000

Aura

Mood, Depression Disorders, Anxiety Disorders, Sleep, Eating Disorders, Physical Activity, Loneliness, Stress

12/25

CRDS Registry, NCT06508164: International

Recruiting

N/A

500

Europe, Canada, RoW

Population Health Research Institute, Canadian Institutes of Health Research (CIHR)

Calcium Release Deficiency Syndrome

12/50

NCT06833268: Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan

Recruiting

N/A

220

No drug

Daiichi Sankyo

HER2-positive Breast Cancer

06/25

Recruiting

N/A

720

RoW

No Drug

Daiichi Sankyo

Diabetic Peripheral Neuropathic Pain

02/26

04/26

PEERS, NCT06696066: Pilot: Peer Recovery Support Program to Support Engagement in Medication for Opioid Use Disorder

Recruiting

N/A

PRS Program

Geisinger Clinic, National Institute on Drug Abuse (NIDA), UConn Health

Opioid Use Disorder

06/25

08/25

RERUN, NCT06809764: Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC

Recruiting

N/A

150

RoW

No drug

Daiichi Sankyo

Non-small Cell Lung Cancer

02/27

Recruiting

N/A

260

RoW

Trastuzumab deruxtecan (T-DXd)

Daiichi Sankyo

HER2-positive Gastric Cancer, HER2-positive Gastroesophageal Junction

07/27

NCT06659900: Community Vital Signs (CVS): an Integrated Community-Based Approach to Identify Undiagnosed Hypertension in Nigeria

Not yet recruiting

N/A

24000

RoW

CORE Plus (+), CORE

Oregon Health and Science University, University of Nigeria Nsukka

Hypertension

06/27

IMPACT, NCT04330833: Informational Meetings for Planning and Coordinating Treatment

Active, not recruiting

N/A

110

Novel Communication Intervention, Enhanced Usual Care Parent Education

Indiana University, National Cancer Institute (NCI)

End of Life, Communication, Cancer Metastatic

07/25

N&HS, NCT06950775: The Neighborhood & Health Study

Not yet recruiting

N/A

600

Residence in Agrihood Neighborhood

Texas A&M University

Healthy Eating, Cardiometabolic Health Indicators

03/26

ASPIRE-II, NCT06668350: Attitudes and Perceptions Attitudes and Smoking Perceptions in the Real Environment -II

Not yet recruiting

N/A

190

Smoking outcomes

University of Oklahoma

Cigarillo Flavor

02/29

06/29

NCT06776406: Head Stabilization in Whole Brain RT

Not yet recruiting

N/A

Freedom Pursuit Robotic Platform

Abramson Cancer Center at Penn Medicine

Brain Cancer

08/27

Safe-De, NCT05058183: Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer

Recruiting

N/A

400

Europe

ctDNA

Royal Marsden NHS Foundation Trust, Massachusetts General Hospital, Natera, Inc.

Breast Cancer

12/25

12/28

NCT05568264: Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

Recruiting

N/A

192

Physical Therapy intervention

Shirley Ryan AbilityLab, Ann & Robert H Lurie Children's Hospital of Chicago, Northwestern University, Northwestern Medicine, University of Illinois at Chicago

Motor Delay, Premature Birth, Intraventricular Hemorrhage, Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia

05/26

12/26

NCT01577251: The Radiation Oncology Registry and Biosample Repository

Recruiting

N/A

8000

Abramson Cancer Center at Penn Medicine

Neoplasia

12/30

Diamond, Lisa

NCT02726360: Physician Use of Non-English Language Skills in Cancer Care

Completed

N/A

survey, ILR Scale, Audio record

Memorial Sloan Kettering Cancer Center, Edward-Elmhurst Health System, Johns Hopkins University, Lincoln Medical and Mental Health Center, Queens Cancer Center of Queens Hospital

Breast Cancer, Colon Cancer, Lung Cancer

08/23

Lee, Frank

OASIS, NCT06527937: Pharmacokinetics Study of DESF in Adults with Oral Allergy Syndrome

Completed

DESF, Epinephrine Injection

Aquestive Therapeutics

Allergic Reaction

10/24

NCT05499260: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants

Recruiting

CB03-154, Placebo

Shanghai Zhimeng Biopharma, Inc.

Healthy Volunteers

03/23

NCT05523570: A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension

Completed

HNC364, HNC364 injectable suspension

Guangzhou Henovcom Bioscience Co. Ltd.

Parkinson's Disease

04/24

NCT05750017: A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine

Recruiting

Low Dose Recombinant Herpes Zoster Vaccine (LZ901), High Dose Recombinant Herpes Zoster Vaccine (LZ901), Placebo, Saline solution

Beijing Luzhu Biotechnology Co., Ltd.

Herpes Zoster, Vaccine-Preventable Diseases

02/24

03/24

Recruiting

ARN-75039

Arisan Therapeutics, Inc.

Lassa Virus Infection

04/25

NCT05504200: Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training

Completed

N/A

Europe

Bladder and Pelvic Floor Muscle Training

RNOH RIC, International Spinal Research Trust

Spinal Cord Injuries

09/23

Prezioso, Alexander N

NCT05611957: A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Completed

LY3437943

Eli Lilly and Company

Healthy, Renal Insufficiency

09/23

NCT05936138: A Study of LY3502970 in Participants With Normal and Impaired Renal Function

Completed

LY3502970

Eli Lilly and Company

Renal Insufficiency, Healthy

04/24

DA-1726-1001, NCT06252220: First in Human Study in Subjects With Obesity, But Otherwise Healthy

Recruiting

DA-1726, Placebo to DA-1726

NeuroBo Pharmaceuticals Inc.

Obesity

03/25

06/25

NCT06498284: Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus

Completed

HM-002-1005, 1005

Hua Medicine Limited

Diabetes Mellitus, Type II

09/24

NCT05882032: A Study of LY3502970 in Participants With Impaired and Normal Liver Function

Completed

LY3502970

Eli Lilly and Company

Healthy, Hepatic Insufficiency

11/24

PMN310-101, NCT06105528: A Phase 1a Study of PMN310 In Healthy Volunteers

Completed

PMN310, Placebo

ProMis Neurosciences, Inc

Healthy Participants

07/24

NCT06606106: A Study of LY3537031 in Overweight, Obese, and Healthy Participants

Recruiting

230

LY3537031, Placebo

Eli Lilly and Company

Healthy, Obesity

07/26

NCT06824051: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight

Active, not recruiting

120

Orforglipron, LY3502970, Placebo

Eli Lilly and Company

Obesity, Overweight

12/25

NCT06916143: Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach Acid

Recruiting

LY4100511, Rabeprazole

Eli Lilly and Company

Healthy Participants

06/25

Liu, Jiabei Jay

No trials found

Christodoro, Dina

No trials found

Kim, Alicia

No trials found

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites